EUROPEAN hemp leaders are to open a new front in the on-going continental cannabidiol (CBD) battle by looking to have it classified again as a traditional food.
Susanne Caspar CEO of Swiss botanical extraction company Linnea SA analyses Europe’s latest CBD deliberations.
THE European Food Safety Authority (EFSA) issued a statement last week announcing that its scientists ‘cannot currently establish the safety of cannabidiol (CBD) as a novel food’.
AFTER a delay of exactly one year the long-awaited Public List of validated UK CBD products has been published by the Food Standards Agency.
AS Brains Bioceutical becomes the latest company to make it on to the Public List of Validated Novel Food CBD applicants, sections of the industry are becoming increasingly unsettled by the ‘unprofessional’ approach of the Food Standards Agency.
THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into the post-prohibition era.
Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022 K-FN: The cannabis industry in Europe in its various sectors – medical, commercial hemp and CBD – has…
In a Q&A with BusinessCann Eoin Keenan, CEO & Co-Founder, Goodrays, says after seven years working in the industry he expects 2022 to be a break-through year BC: What developments should we expect to see in the European cannabis industry in 2022?
MUCH-AWAITED guidance on the permitted levels of THC in UK CBD products has been met with a mixed response and sparked some concerns over the future direction of travel for the industry.
